Literature DB >> 7529414

The chemistry of signal transduction.

J Clardy1.   

Abstract

Several disciplines, including chemical ecology, seek to understand the molecular basis of information transfer in biological systems, and general molecular strategies are beginning to emerge. Often these strategies are discovered by a careful analysis of natural products and their biological effects. Cyclosporin A, FK506, and rapamycin are produced by soil microorganisms and are being used or considered as clinical immunosuppressive agents. They interrupt the cytoplasmic portion of T-cell signaling by forming a complex with a binding protein--FKBP12 in the case of FK506 and rapamycin and cyclophilin A (CyPA) in the case of cyclosporin A (CsA). This complex in turn inhibits a protein target, and the best understood target is calcineurin, which is inhibited by FK506-FKBP12 and CyPA-CsA. Mutational and structural studies help define how FK506-FKBP12 interacts with calcineurin, and the results of these studies are summarized. The existence of strong FK506-FKBP12 binding suggests that FK506 is mimicking some natural ligand for FKBP12. Synthetic and structural studies to probe this mimicry are also described.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7529414      PMCID: PMC42816          DOI: 10.1073/pnas.92.1.56

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

Review 1.  Chemistry and biology of the immunophilins and their immunosuppressive ligands.

Authors:  S L Schreiber
Journal:  Science       Date:  1991-01-18       Impact factor: 47.728

2.  Atomic structure of FKBP-FK506, an immunophilin-immunosuppressant complex.

Authors:  G D Van Duyne; R F Standaert; P A Karplus; S L Schreiber; J Clardy
Journal:  Science       Date:  1991-05-10       Impact factor: 47.728

3.  Solution structure of FKBP, a rotamase enzyme and receptor for FK506 and rapamycin.

Authors:  S W Michnick; M K Rosen; T J Wandless; M Karplus; S L Schreiber
Journal:  Science       Date:  1991-05-10       Impact factor: 47.728

Review 4.  Why are secondary metabolites (natural products) biosynthesized?

Authors:  D H Williams; M J Stone; P R Hauck; S K Rahman
Journal:  J Nat Prod       Date:  1989 Nov-Dec       Impact factor: 4.050

5.  A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase.

Authors:  M W Harding; A Galat; D E Uehling; S L Schreiber
Journal:  Nature       Date:  1989-10-26       Impact factor: 49.962

6.  Sensitivity to cyclosporin A is mediated by cyclophilin in Neurospora crassa and Saccharomyces cerevisiae.

Authors:  M Tropschug; I B Barthelmess; W Neupert
Journal:  Nature       Date:  1989 Dec 21-28       Impact factor: 49.962

7.  Cyclosporin A specifically inhibits function of nuclear proteins involved in T cell activation.

Authors:  E A Emmel; C L Verweij; D B Durand; K M Higgins; E Lacy; G R Crabtree
Journal:  Science       Date:  1989-12-22       Impact factor: 47.728

8.  FKB1 encodes a nonessential FK 506-binding protein in Saccharomyces cerevisiae and contains regions suggesting homology to the cyclophilins.

Authors:  G Wiederrecht; L Brizuela; K Elliston; N H Sigal; J J Siekierka
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

9.  FK-506-binding protein: three-dimensional structure of the complex with the antagonist L-685,818.

Authors:  J W Becker; J Rotonda; B M McKeever; H K Chan; A I Marcy; G Wiederrecht; J D Hermes; J P Springer
Journal:  J Biol Chem       Date:  1993-05-25       Impact factor: 5.157

10.  Solution structure of FK506 bound to FKBP-12.

Authors:  C A Lepre; J A Thomson; J M Moore
Journal:  FEBS Lett       Date:  1992-05-04       Impact factor: 4.124

View more
  18 in total

Review 1.  Immune mechanisms in uveitis.

Authors:  R R Caspi
Journal:  Springer Semin Immunopathol       Date:  1999

2.  A ligand-reversible dimerization system for controlling protein-protein interactions.

Authors:  C T Rollins; V M Rivera; D N Woolfson; T Keenan; M Hatada; S E Adams; L J Andrade; D Yaeger; M R van Schravendijk; D A Holt; M Gilman; T Clackson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

3.  Modulation of type-1 Ins(1,4,5)P3 receptor channels by the FK506-binding protein, FKBP12.

Authors:  Sheila L Dargan; Edward J A Lea; Alan P Dawson
Journal:  Biochem J       Date:  2002-01-15       Impact factor: 3.857

Review 4.  Borrowing to make ends meet.

Authors:  J Clardy
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

5.  The evolution of gene collectives: How natural selection drives chemical innovation.

Authors:  Michael A Fischbach; Christopher T Walsh; Jon Clardy
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-23       Impact factor: 11.205

6.  Isolation, cloning and characterization of a low-molecular-mass purine nucleoside- and nucleotide-binding protein.

Authors:  J Gilmour; N Liang; J M Lowenstein
Journal:  Biochem J       Date:  1997-09-01       Impact factor: 3.857

7.  Crystal structures of HINT demonstrate that histidine triad proteins are GalT-related nucleotide-binding proteins.

Authors:  C Brenner; P Garrison; J Gilmour; D Peisach; D Ringe; G A Petsko; J M Lowenstein
Journal:  Nat Struct Biol       Date:  1997-03

8.  Constitutive activation of S6 kinase by deletion of amino-terminal autoinhibitory and rapamycin sensitivity domains.

Authors:  M Mahalingam; D J Templeton
Journal:  Mol Cell Biol       Date:  1996-01       Impact factor: 4.272

Review 9.  Chemical ecology: a view from the pharmaceutical industry.

Authors:  L H Caporale
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-03       Impact factor: 11.205

10.  Structure comparison of native and mutant human recombinant FKBP12 complexes with the immunosuppressant drug FK506 (tacrolimus).

Authors:  S Itoh; M A Navia
Journal:  Protein Sci       Date:  1995-11       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.